newsfilter
← Latest News
GlobeNewswire·

PDS Biotech Announces Conference Call and Webcast for Third Quarter 2025 Financial Results

PRINCETON, N.J., Nov. 06, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (NASDAQ:PDSB) ("PDS Biotech" or the "Company"), a late-stage immunotherapy company focused on transforming how the immune system targets